Chrysin inhibits lipopolysaccharide-induced angiogenesis via down-regulation of VEGF/VEGFR-2(KDR) and IL-6/IL-6R pathways

Planta Medica

Volumn 72, Issue 8, 2006, Pages 708-714

  Lin, Chiu Mei ^a,b   Chang, Hang ^c,d   Li, Shih Yun ^a   Wu, I Hsing ^b   Chiu, Jen Hwey ^a,e,f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

Author keywords

Angiogenesis; Chrysin; KDR; Lipopolysaccharide; VEGF

Indexed keywords

CHRYSIN; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LIPOPOLYSACCHARIDE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; ASSAY; AUTOREGULATION; CHORIOALLANTOIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG MECHANISM; DRUG STRUCTURE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; UMBILICUS; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; ANIMALS; CHICKENS; CHORIOALLANTOIC MEMBRANE; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FLAVONOIDS; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; NEOVASCULARIZATION, PHYSIOLOGIC; PHYTOTHERAPY; PLANTS, MEDICINAL; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; UMBILICAL VEINS;

EID: 33746075933     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-931602     Document Type: Article

References (30)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31
2. Karin M. Inflammation and cancer: the long reach of Ras. Nat Med 2005; 11: 20-1
3. Lubarsky B, Krasnow MA. Tube morphogenesis making and shaping biological tubes. Cell 2003; 112: 19-28
4. Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular disease: a focus on endothelial responses to inflammation. Clin Sci 2005; 108: 205-13
5. Risau W. Mechanism of angiogenesis. Nature 1997; 386: 671-4
6. Molostvov G, Morris A, Rose P, Basu S, Muller G. The effects of selective cytokines inhibiting drugs (CC-10 004 and CC-1088) on VEGF and IL-6 expression and apoptosis in myeloma and endothelial cell co-cultures. Brit J Haematol 2004; 124: 366-75
7. Kozian DH, Augustin HG. Rapid identification of differentially expresses endothelial cell genes by RNA-display. Biochem Biophys Res Commun 1995; 209: 1068-75
8. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 2004; 25: 581-611
9. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J 2003; 374: 1-20
10. Modur V, Li Y, Zimmerman GA, Prescott SM, Mclintyre TM. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest 1997; 100: 2752-6
11. Cohen T, Nahari D, Cerem LW, Levi BZ. Interleukin 6 induced the expression of vascular endothelial growth factor. J Biol Chem 1996; 271: 736-41
12. Morin V, Montero-Julian FA, Gres S, Boulay V, Bongrand P, Farnarier C et al. The IL-6, soluble IL-6Rα autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation an experimental model involving thrombin. J Immunol 2001; 167: 3435-42
13. Monasterio A, Urdaci MC, Pinchuk IV, Lopez-Moratalla N, Martinez-Irujo JJ. Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain-dependent pathways. Nutr Cancer 2004; 50: 90-100
14. Weng MS, Ho YS, Lin JK. Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21(Waf1/Cip1) expression: Involvement of p38 mitogen-activated protein kinase. Biochem Pharmacol 2005; 69: 1815-27
15. Woo KJ, Jeong YJ, Inoue H, Park JW, Kwon TK. Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA-binding activity. FEBS Lett 2005; 31: 705-11
16. Hougee S, Sanders A, Faber J, Graus YM, van den Berg WB, Graessen J. Decreased pro-inflammatory cytokine production by LPS-stimulates PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin due to selective elimination of monocytes/macrophages. Biochem Pharmacol 2005; 15: 241-8
17. Yang SH, Lin JK, Huang CJ, Chen WS, Li SY, Chiu JH. Silibinin inhibits angiogenesis via Flt-1, but not KDR, receptor up-regulation. J Surg Res 2005; 128: 140-6
18. Jeffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-56
19. Unger RE, Peters K, Huang Q, Funk A, Paul D, Kirkpatrick CJ. Vascularization and gene regulation of human endothelial cells growing on porous polyethersulfone (PES) hollow fiber membranes. Biomaterials 2005; 26: 3461-9
20. Pollet I, Opina CJ, Zimmerman C, Leong KG, Wong F, Karsan A. Bacterial lipopolysaccharide directly induces Angiogenesis through TRAF6-mediated activation of NF-κB and c-Jun N-terminal kinase. Blood 2003; 102: 1740-2
21. Lin SK, Tsai SC, Lee CC, Wang BW, Liou JY, Shyu KG. Berberine inhibits HIF-1 expression via enhanced proteolysis. Mol Pharmacol 2004; 66: 612-9
22. Grant DS, Tashiro K, Segui-Real B, Yamada Y, Martin GR, Kleinman HK. Two differentiations of human endothelial cells into capillary-like structures in vitro. Cell 1989; 58: 933-43
23. Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 1990; 63: 15-22
24. Lay IS, Chiu JH, Shiao MS, Lui WY, Wu CW. Crude extract of Salvia mitiorrhiza and Salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta Med 2002; 68: 1-7
25. Liu JJ, Huang TS, Cheng WF, Lu FJ. Baicalein and baicalin are potent inhibitors of angiogenesis: inhibition of endothelial cell proliferation, migration and differentiation. Int J Cancer 2003; 106: 559-65
26. Melzig MF, Loose R. Inhibition of liposaccharide (LPS)-induced endothelial cytotoxicity by selected flavonoids. Planta Med 1998; 64: 397-9
27. Salven P, Hattori K, Heissig B, Rafii S. Interleukin-1α promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FESEB J 2002; 16: 1471-3
28. Ravindranath MH, Muthugounder S, Presser N, Viswanathan S. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 2004; 546: 121-65
29. Fang J, Xia C, Cao Z, Zheng JZ, Reed E, Jiang BH. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB J 2005; 19: 342-53
30. Jurtujara K, Raghow R, Laulederkind SJ, Goorha S, Kanekura T, Ballou LR. Transcriptional regulation of cyclooxygenase-2 in the human microvascular endothelial cell line, HMEC-1: control by the combinatorial actions of AP2, NF-IL-6 and CRE elements. Mol Cell Biochem 2000; 203: 41-51